Oriental Precision & Engineering Co (XKRX:014940) 3-Year EBITDA Growth Rate : -24.80% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Oriental Precision & Engineering Co 3-Year EBITDA Growth Rate?

Oriental Precision & Engineering Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩124.78.

During the past 12 months, Oriental Precision & Engineering Co's average EBITDA Per Share Growth Rate was 19.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -24.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 39.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Oriental Precision & Engineering Co was 106.90% per year. The lowest was -63.50% per year. And the median was 23.00% per year.

Competitive Comparison of Oriental Precision & Engineering Co's 3-Year EBITDA Growth Rate

For the Aerospace & Defense subindustry, Oriental Precision & Engineering Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oriental Precision & Engineering Co's 3-Year EBITDA Growth Rate Distribution in the Aerospace & Defense Industry

For the Aerospace & Defense industry and Industrials sector, Oriental Precision & Engineering Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Oriental Precision & Engineering Co's 3-Year EBITDA Growth Rate falls into.

Oriental Precision & Engineering Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Oriental Precision & Engineering Co (XKRX:014940) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Oriental Precision & Engineering Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Oriental Precision & Engineering Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Oriental Precision & Engineering Co (XKRX:014940) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Aerospace & Defense » Oriental Precision & Engineering Co Ltd (XKRX:014940) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1614-1 Songjeong-dong, Gangseo-gu, Busan, KOR

Website

http://eng.opco.co.kr

Oriental Precision & Engineering Co Ltd engages in the manufacture machineries and equipment for ships. It products include lifting appliances, engine room crane,engine room casings, funnels, and hull blocks; and machineries, such as deck, hose handling, provision, knuckle, electric slewing, monorail, offshore, jib, and gantry cranes, life saving appliances, deck machinery, deck house, engine room casing, funnel, and living quarter.

Oriental Precision & Engineering Co (XKRX:014940) Headlines

No Headlines